Fosun Pharma Buys Back 1.34 Million Shares for HKD 21.86 Million, Third Straight Day
Fosun Pharma (02196. HK) repurchased 1.34 million shares on September 11, 2026, at HKD 16.140 to HKD 16.500 per share, for HKD 21.8642 million. The stock closed at HKD 16.330, down 1.09%, on turnover of HKD 104 million. The buyback marked a third consecutive session, totaling 2.7825 million shares for HKD 45.9086 million, during which the stock fell 5.39%. So far in 2026, the company has repurchased 3.404 million shares for HKD 56.0795 million across seven transactions.
Fosun Pharma (02196. HK) said in a Hong Kong Stock Exchange filing that on September 11, 2026 it repurchased 1.34 million shares at prices ranging from HKD 16.140 to HKD 16.500, for a total of HKD 21.8642 million. The stock closed that day at HKD 16.330, down 1.09%, with full-day turnover of HKD 104 million.
Since September 9, 2026, Fosun Pharma has repurchased shares on three consecutive trading days, buying back a combined 2.7825 million shares for HKD 45.9086 million. Over that period the stock fell 5.39% cumulatively. So far in 2026, the company has carried out seven repurchases, totaling 3.404 million shares for HKD 56.0795 million.
According to the disclosed repurchase details: on September 11, 2026, 1.34 million shares were repurchased at HKD 16.140 to HKD 16.500, for HKD 21.8642 million; on September 10, 1.29 million shares at HKD 16.400 to HKD 16.870, for HKD 21.4146 million; on September 9, 152,500 shares at HKD 17.160 to HKD 17.260, for HKD 2.6298 million; on September 7, 70,000 shares at HKD 16.740 to HKD 16.830, for HKD 1.1752 million; on September 1, 264,000 shares at HKD 16.070 to HKD 16.280, for HKD 4.2784 million; on August 31, 70,500 shares at HKD 16.010 to HKD 16.050, for HKD 1.1302 million; and on August 27, 217,000 shares at HKD 16.450 to HKD 16.590, for HKD 3.587 million.